Overview

NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy

Status:
Completed

Trial end date:
2017-07-03

Target enrollment:

Participant gender:

Summary

To assess whether the daily use of NeutraSal will prevent or reduce dry mouth in patients undergoing CPAP therapy for OSAS and improve CPAP compliance

Phase:

N/A

Details

Lead Sponsor:

Medical University of South Carolina

Collaborator:

Invado Pharmaceuticals LLC